In last trading session, Cyclerion Therapeutics Inc (NASDAQ:CYCN) saw 29.83 million shares changing hands with its beta currently measuring 1.80. Company’s recent per share price level of $2.16 trading at $0.8 or 58.82% at ring of the bell on the day assigns it a market valuation of $9.29M. That closing price of CYCN’s stock is at a discount of -143.06% from its 52-week high price of $5.25 and is indicating a premium of 41.2% from its 52-week low price of $1.27. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.36 million shares which gives us an average trading volume of 226.92K if we extend that period to 3-months.
Cyclerion Therapeutics Inc (NASDAQ:CYCN) trade information
Upright in the green during last session for gaining 58.82%, in the last five days CYCN remained trading in the green while hitting it’s week-highest on Wednesday, 11/27/24 when the stock touched $2.16 price level, adding 7.69% to its value on the day. Cyclerion Therapeutics Inc’s shares saw a change of -35.52% in year-to-date performance and have moved 3.35% in past 5-day. Cyclerion Therapeutics Inc (NASDAQ:CYCN) showed a performance of -28.95% in past 30-days. Number of shares sold short was 14439.0 shares which calculate 0.78 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 36.06% during past 5 years.
Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s Major holders
Insiders are in possession of 21.90% of company’s total shares while institution are holding 40.41 percent of that, with stock having share float percentage of 51.74%. Investors also watch the number of corporate investors in a company very closely, which is 40.41% institutions for Cyclerion Therapeutics Inc that are currently holding shares of the company.
On the other hand, Fidelity Select Portfolios – Biotechnology and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 38.31 shares of worth $82760.0 or 1.41% of the total outstanding shares. The later fund manager was in possession of 23.49 shares on Jun 30, 2024 , making its stake of worth around $50738.0 in the company or a holder of 0.87% of company’s stock.
